HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Alejandro Martin Sanchez Selected Research

Neoplasms (Cancer)

5/2023Local Treatment of Triple-Negative Breast Cancer: Is Mastectomy Superior to Breast-Conserving Surgery?
12/2022Efficacy and safety of neoadjuvant pertuzumab plus trastuzumab in combination with chemotherapy regimen in Chinese patients with HER2-positive early breast cancer: a real-world retrospective multi-center cohort study.
1/2022Paget's disease of the breast: Our 20 years' experience.
1/2020Update on sentinel lymph node biopsy after neoadjuvant chemotherapy in breast cancer patient.
3/2016Penile cancer metastasizing to the breast: a case report.
1/2016Reduction mammoplasty using oxidized regenerated cellulose as a filler in breast conservation surgery.
9/2015Oxidized regenerated cellulose in breast surgery: experimental model.
3/2015Update on the surgical management of breast cancer.
1/2015Anastomotic leakage after anterior resection for rectal cancer with mesorectal excision: incidence, risk factors, and management.
1/2015Quadrantectomy with oxidized regenerated cellulose ("QUORC"): an innovative oncoplastic technique in breast conserving surgery.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Alejandro Martin Sanchez Research Topics

Disease

18Breast Neoplasms (Breast Cancer)
06/2023 - 01/2015
10Neoplasms (Cancer)
05/2023 - 01/2015
3Margins of Excision
01/2016 - 01/2015
2Neoplasm Metastasis (Metastasis)
06/2023 - 05/2023
1Triple Negative Breast Neoplasms
05/2023
1Noninfiltrating Intraductal Carcinoma (DCIS)
11/2022
1Alopecia (Baldness)
01/2022
1COVID-19
01/2021
1Lymphedema (Milroy Disease)
01/2020
1Pathologic Complete Response
01/2020
1Seroma
01/2020
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
03/2016
1Fibrosis (Cirrhosis)
09/2015
1Inflammation (Inflammations)
09/2015
1Stomach Neoplasms (Stomach Cancer)
08/2008

Drug/Important Bio-Agent (IBA)

34-(2-oxapentadeca-4-yne)phenylpropanoic acidIBA
01/2016 - 01/2015
2human ERBB2 proteinIBA
05/2023 - 12/2022
2purified rayonIBA
01/2016 - 01/2015
1MucinsIBA
06/2023
1Estrogen ReceptorsIBA
05/2023
1Progesterone Receptors (Progesterone Receptor)IBA
05/2023
1pertuzumabIBA
12/2022
1Trastuzumab (Herceptin)FDA Link
12/2022
1taxaneIBA
01/2022
1AnthracyclinesIBA
01/2022
1MicroRNAs (MicroRNA)IBA
08/2021
1Biomarkers (Surrogate Marker)IBA
08/2021
1Capsules (Microcapsules)IBA
09/2015
1Dihydrotachysterol (AT 10)IBA
09/2015

Therapy/Procedure

9Mastectomy (Mammectomy)
05/2023 - 01/2015
7Segmental Mastectomy (Lumpectomy)
05/2023 - 01/2015
6Neoadjuvant Therapy
12/2022 - 01/2020
4Drug Therapy (Chemotherapy)
12/2022 - 03/2015
3Radiotherapy
09/2015 - 01/2015
2Mammaplasty (Breast Reconstruction)
01/2021 - 01/2016
1Adjuvant Chemotherapy
01/2022
1Operative Surgical Procedures
01/2022
1Preoperative Exercise
04/2021
1Metastasectomy
03/2021
1Precision Medicine
07/2019
1Aftercare (After-Treatment)
03/2016
1Therapeutics
03/2016
1Lymph Node Excision (Lymph Node Dissection)
03/2016
1Radical Mastectomy
03/2015
1Gastrectomy
08/2008